BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18697798)

  • 1. Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.
    González E; Neuhaus T; Kemper MJ; Girardin E
    Nephrol Dial Transplant; 2009 Jan; 24(1):149-55. PubMed ID: 18697798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.
    Lin CY; Chien JW
    Acta Paediatr Taiwan; 2004; 45(2):77-80. PubMed ID: 15335115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-3 is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome.
    Komatsuda A; Wakui H; Iwamoto K; Togashi M; Masai R; Maki N; Sawada K
    Clin Nephrol; 2009 Jun; 71(6):608-16. PubMed ID: 19473628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood lymphocyte subsets in idiopathic nephrotic syndrome of childhood.
    Bagga A; Vasudev AS; Moudgil A; Srivastava RN
    Indian J Med Res; 1996 Nov; 104():292-5. PubMed ID: 8979520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.
    Komatsuda A; Wakui H; Iwamoto K; Harada M; Okumoto Y; Sawada K
    Am J Nephrol; 2008; 28(4):539-47. PubMed ID: 18219197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism].
    Watanabe Y; Suzui J; Ichikawa Y; Yoshida K; Suzuki H
    Arerugi; 1995 May; 44(5):547-55. PubMed ID: 7619008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Shear stress-induced platelet aggregation in children with minimal change nephrotic syndrome].
    Takagawa K; Nakajima M; Taira K; Sakagami Y; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Takahashi Y; Fujimura Y; Kamitsuji H; Yoshioka A
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):380-8. PubMed ID: 12073623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease.
    Wei CL; Cheung W; Heng CK; Arty N; Chong SS; Lee BW; Puah KL; Yap HK
    Nephrol Dial Transplant; 2005 Apr; 20(4):728-34. PubMed ID: 15728267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephrotic syndrome patients.
    Zhang L; Dai Y; Peng W; Lu J; Zhang Y; Wang L
    Am J Nephrol; 2009; 30(6):505-13. PubMed ID: 19797895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peripheral blood mononuclear cells from patients with nephrotic syndrome on uptake of 35sulfate by glomerular basement membrane.
    Garin EH; Boggs KP
    Int J Pediatr Nephrol; 1985; 6(3):189-94. PubMed ID: 4055237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concanavalin A on nephrotic peripheral blood mononuclear cells mediated increased 35sulfate uptake in rat glomerular basement membrane.
    Garin EH; Boggs KP
    Pediatr Res; 1986 Apr; 20(4):321-3. PubMed ID: 3703621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the relapse and remission periods on hearing status in children with minimal change nephrotic syndrome.
    Bayazit YA; Balat A; Pakir HI; Güler E; Kanlikama M
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(3):171-3. PubMed ID: 16366385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
    Ozaki T
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
    Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
    Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
    Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
    Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS).
    Lahdenkari AT; Kestilä M; Holmberg C; Koskimies O; Jalanko H
    Kidney Int; 2004 May; 65(5):1856-63. PubMed ID: 15086927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
    Yoshizawa N; Kusumi Y; Matsumoto K; Oshima S; Takeuchi A; Kawamura O; Kubota T; Kondo S; Niwa H
    Nephron; 1989; 51(3):370-6. PubMed ID: 2918948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.